Global COVID-19 vaccine inequity: Preferences for overseas vaccine donations over booster shots

Bar-On, 2021, Protection of BNT162b2 vaccine booster against Covid-19 in Israel, N. Engl. J. Med., 385, 1393, 10.1056/NEJMoa2114255 2021 Bollyky Çakmaklı, 2021 Callaway, 2021, COVID vaccine boosters: The most important questions, Nature, 596, 178, 10.1038/d41586-021-02158-6 Clarke, 2021, Public opinion on global rollout of COVID-19 vaccines, Nat. Med., 27, 935, 10.1038/s41591-021-01322-9 Duch, 2021, Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities, Proc. Natl. Acad. Sci. Unit. States Am., 118, 10.1073/pnas.2026382118 Engelmann, 2004, Inequality aversion, efficiency, and maximin preferences in simple distribution experiments, Am. Econ. Rev., 94, 857, 10.1257/0002828042002741 Enke, 2021, Moral universalism: Measurement and economic relevance, Manag. Sci., Aug. Falk, 2018, Global evidence on economic preferences, Q. J. Econ., 133, 1645, 10.1093/qje/qjy013 Feinmann, 2021, Covid-19: Global vaccine production is a mess and shortages are down to more than just hoarding, BMJ, 375 Fidler, 2020 Garcia-Beltran, 2022, mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant, Cell, 185, 457, 10.1016/j.cell.2021.12.033 Gruszczynski, 2021, Between the high ideals and reality: Managing COVID-19 vaccine nationalism, Eur. J. Risk Regul., 12, 711, 10.1017/err.2021.9 Hafner, 2020 Heffner, 2021, Emotional responses to prosocial messages increase willingness to self-isolate during the COVID-19 pandemic, Pers. Indiv. Differ., 170, 110420, 10.1016/j.paid.2020.110420 Ho, 2020, Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants, PLoS One, 15, e0241824, 10.1371/journal.pone.0241824 Hogan, 2020 Iacobucci, 2022, Covid-19: Fourth vaccine doses—who needs them and why?, BMJ, 376 2021 Jordan, 2021, Don’t get it or don’t spread it: Comparing self-interested versus prosocial motivations for COVID-19 prevention behaviors, Sci. Rep., 11, 10.1038/s41598-021-97617-5 Levin, 2021, Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months, N. Engl. J. Med., 10.1056/NEJMoa2114583 Padma, 2021, COVID vaccines to reach poorest countries in 2023 — despite recent pledges, Nature, 595, 342, 10.1038/d41586-021-01762-w Palan, 2018, Prolific.ac - A subject pool for online experiments, J. Behav. Exp. Finance, 17, 22, 10.1016/j.jbef.2017.12.004 Peer, 2016, Beyond the Turk: Alternative platforms for Crowdsourcing Behavioral Research Prolific Team, 2022. Representative Samples. Prolific. Accessed Nov. 20, 2021. [Online]. Available: https://researcher-help.prolific.co/hc/en-gb/articles/360019236753-Representative-samples. Ritchie, 2020 Robertson, 2021, Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study, Brain Behav. Immun., 94, 41, 10.1016/j.bbi.2021.03.008 Schaefer, 2021, Making vaccines available to other countries before offering domestic booster vaccinations, JAMA, 10.1001/jama.2021.13226 Tartof, 2021, Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study, The Lancet, 398, 1407, 10.1016/S0140-6736(21)02183-8 Vanderslott, 2021, Vaccine nationalism and internationalism: Perspectives of COVID-19 vaccine trial participants in the United Kingdom, BMJ Glob. Health, 6, e006305, 10.1136/bmjgh-2021-006305 Wouters, 2021, Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment, The Lancet, 397, 1023, 10.1016/S0140-6736(21)00306-8 Yamin, 2022, Vaccine inequality benefits no one, Nat. Hum. Behav., 1 Ye, 2022, Equitable access to COVID-19 vaccines makes a life-saving difference to all countries, Nat. Hum. Behav., 1